Excellent outcomes reported for first targeted frontline therapy for high-risk pediatric Hodgkin lymphoma
Date Time Excellent outcomes reported for first targeted frontline therapy for high-risk pediatric Hodgkin lymphoma (From left) First and corresponding author Monika Metzger, M.D., Departments of Oncology and Global Pediatric Medicine; co- senior author Matthew Krasin, M.D., Department of Radiation Oncology; and co-senior author Melissa Hudson, M.D., Cancer Survivorship Division director. Scientists are reporting results of the first frontline clinical trial to use targeted therapy to treat high-risk pediatric Hodgkin lymphoma. The study showed that the addition of brentuximab vedotin achieve...